Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

STO:CLS.B Statistics

Total Valuation

STO:CLS.B has a market cap or net worth of SEK 282.37 million. The enterprise value is 263.59 million.

Market Cap	282.37M
Enterprise Value	263.59M

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:CLS.B has 25.67 million shares outstanding. The number of shares has increased by 181.65% in one year.

Current Share Class	25.67M
Shares Outstanding	25.67M
Shares Change (YoY)	+181.65%
Shares Change (QoQ)	+19.79%
Owned by Insiders (%)	12.97%
Owned by Institutions (%)	14.53%
Float	22.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.83
PB Ratio	4.38
P/TBV Ratio	4.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.10
EV / Sales	11.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.41

Financial Position

The company has a current ratio of 4.49, with a Debt / Equity ratio of 0.00.

Current Ratio	4.49
Quick Ratio	3.38
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-86.68

Financial Efficiency

Return on equity (ROE) is -83.79% and return on invested capital (ROIC) is -42.06%.

Return on Equity (ROE)	-83.79%
Return on Assets (ROA)	-32.75%
Return on Invested Capital (ROIC)	-42.06%
Return on Capital Employed (ROCE)	-54.29%
Revenue Per Employee	1.84M
Profits Per Employee	-3.32M
Employee Count	13
Asset Turnover	0.36
Inventory Turnover	0.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +105.61% in the last 52 weeks. The beta is -0.18, so STO:CLS.B's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	+105.61%
50-Day Moving Average	5.61
200-Day Moving Average	3.93
Relative Strength Index (RSI)	68.64
Average Volume (20 Days)	292,802

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:CLS.B had revenue of SEK 23.88 million and -43.21 million in losses. Loss per share was -2.28.

Revenue	23.88M
Gross Profit	17.67M
Operating Income	-34.98M
Pretax Income	-43.27M
Net Income	-43.21M
EBITDA	-34.68M
EBIT	-34.98M
Loss Per Share	-2.28

Balance Sheet

The company has 16.20 million in cash and 224,000 in debt, giving a net cash position of 15.98 million or 0.62 per share.

Cash & Cash Equivalents	16.20M
Total Debt	224,000
Net Cash	15.98M
Net Cash Per Share	0.62
Equity (Book Value)	64.43M
Book Value Per Share	2.62
Working Capital	26.74M

Cash Flow

In the last 12 months, operating cash flow was -42.88 million and capital expenditures -5.86 million, giving a free cash flow of -48.74 million.

Operating Cash Flow	-42.88M
Capital Expenditures	-5.86M
Free Cash Flow	-48.74M
FCF Per Share	-1.90

Margins

Gross margin is 73.99%, with operating and profit margins of -146.50% and -180.95%.

Gross Margin	73.99%
Operating Margin	-146.50%
Pretax Margin	-181.23%
Profit Margin	-180.95%
EBITDA Margin	-145.22%
EBIT Margin	-146.50%
FCF Margin	n/a

Dividends & Yields

STO:CLS.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-181.65%
Shareholder Yield	n/a
Earnings Yield	-15.30%
FCF Yield	-17.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 25, 2024. It was a reverse split with a ratio of 0.005.

Last Split Date	Apr 25, 2024
Split Type	Reverse
Split Ratio	0.005

Scores

STO:CLS.B has an Altman Z-Score of 4.96 and a Piotroski F-Score of 4.

Altman Z-Score	4.96
Piotroski F-Score	4